Adrenal and thyroid axis function in preterm ventilated baboons

Biology of the Neonate

Volumn 83, Issue 3, 2003, Pages 208-216

  Jobe, Alan H ^a   Scott, Susan M ^b   Polk, Daniel H ^c   Seidner, Steven R ^d  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Adrenocorticotropin; Bronchopulmonary dysplasia; Corticotropin releasing hormone; Cortisol; Thyroxine treatments

Indexed keywords

BETAMETHASONE ACETATE PLUS BETAMETHASONE SODIUM PHOSPHATE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE; LUNG SURFACTANT EXTRACT; PROTIRELIN; THYROXINE;

ADRENAL FUNCTION; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSISTED VENTILATION; BABOON; CONTROLLED STUDY; CORTICOTROPIN TEST; DRUG EXPOSURE; FEMALE; GESTATIONAL AGE; HORMONE RESPONSE; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LUNG DYSPLASIA; NEWBORN; NONHUMAN; PREMATURE LABOR; PREMATURITY; PRENATAL EXPOSURE; PRENATAL PERIOD; PRIORITY JOURNAL; PROTIRELIN TEST; STRESS; THYROID FUNCTION; THYROXINE BLOOD LEVEL;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANIMALS, NEWBORN; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HYDROCORTISONE; LUNG DISEASES; PAPIO; RESPIRATION, ARTIFICIAL; THYROID GLAND; THYROXINE;

ANIMALIA; PAPIO;

EID: 0037229841     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068922     Document Type: Article

References (45)

1. Ballard PL: Hormones and Lung Maturation. Monographs on Endocrinology. New York, Springer, 1986.
2. Burrow GN, Fisher DA, Larsen PR: Maternal and fetal thyroid function. N Engl J Med 1994;331:1072-1078.
3. Crowley P: Antenatal corticosteroid therapy: A meta-analysis of the randomized trials - 1972-1994. Am J Obstet Gynecol 1995;173:322-335.
4. Ballard PL, Ballard RA: Scientific basis and therapeutic regiments for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995;173:254-262.
5. Ervin MG, Seidner SR, Leland MM, Ikegami M, Jobe AH: Direct fetal glucocorticoid treatment alters postnatal adaptation in premature newborn baboons. Am J Physiol 1998;274:R1169-R1176.
6. al-Dahan J, Stimmler L, Chantler C, Haycock GB: The effect of antenatal dexamethasone administration on glomerular filtration rate and renal sodium excretion in premature infants. Pediatr Nephrol 1987;1:131-135.
7. Moise AA, Wearden ME, Kozinetz CA, Gest AL, Welty SE, Hansen TN: Antenatal steroids are associated with less need for blood pressure support in extremely premature infants. Pediatrics 1995;95:845-850.
8. Berry LM, Polk DH, Ikegami M, Jobe AH, Padbury JF, Ervin MG: Preterm newborn lamb renal and cardiovascular responses after fetal or maternal antenatal betamethasone. Am J Physiol 1997;272:R1972-R1979.
9. Clyman RI, Ballard PL, Sniderman S, Ballard RA, Roth R, Heymann MA, Granberg JP: Prenatal administration of betamethasone for prevention of patent ductus arteriosus. J Pediatr 1981;98:123-126.
10. Murphy BE: Human fetal serum cortisol levels related to gestational age: Evidence of a midgestational fall and a steep late gestational rise, independent of sex or mode of delivery. Am J Obstet Gynecol 1982;144:276-282.
11. Jett PL, Samuels MH, McDaniel PA, Benda GI, Lafranchi SH, Reynolds JW, Hanna CE: Variability of plasma cortisol levels in extremely low birth weight infants. J Clin Endocrinol Metab 1997;82:2921-2925.
12. Watterberg KL, Scott SM: Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia. Pediatrics 1995;95:120-125.
13. Huysman MW, Hokken-Koelega AC, De Ridder MA, Sauer PJ: Adrenal function in sick very preterm infants. Pediatr Res 2000;48:629-633.
14. Watterberg KL, Gerdes JS, Cook KL: Impaired glucocorticoid synthesis in premature infants developing chronic lung disease. Pediatr Res 2001;50:190-195.
15. Korte C, Styne D, Merritt TA, Mayes D, Wertz A, Helbock HJ: Adrenocortical function in the very low birth weight infant: Improved testing sensitivity and association with neonatal outcome. J Pediatr 1996;128:257-263.
16. Ng PC, Wong GW, Lam CW, Lee CH, Wong MY, Fok TF, Wong W, Chan DC: The pituitary-adrenal responses to exogenous human corticotropin-releasing hormone in preterm, very low birth weight infants. J Clin Endocrinol Metab 1997;82:797-799.
17. Gaissmaier RE, Pohlandt F: Single-dose dexamethasone treatment of hypotension in preterm infants. J Pediatr 1999;134:701-705.
18. Watterberg KL, Scott SM, Backstrom C, Gifford KL, Cook KL: Links between early adrenal function and respiratory outcome in preterm infants: Airway inflammation and patent ductus arteriosus. Pediatrics 2000,105:320-324.
19. Banks BA, Stouffer N, Cnaan A, Ning Y, Merril JD, Ballard RA, Ballard PL: Association of plasma cortisol and chronic lung disease in preterm infants. Pediatrics 2001;107:494-498.
20. Padbury JF, Polk DH, Newnham JP, Lam RW: Neonatal adaptation: Greater sympathoadrenal response in preterm than full-term fetal sheep at birth. Am J Physiol 1985;248:E443-E449.
21. Padbury JF, Ervin MG, Polk DH: Extrapulmonary effects of antenatally administered steroids. J Pediatr 1996;128:167-172.
22. Watterberg KL, Gerdes JS, Gifford KL, Lin HM: Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics 1999;104:1258-1263.
23. Fisher DA, Nelson JC, Carlton EI, Wilcox RB: Maturation of human hypothalamic-pituitary-thyroid function and control. Thyroid 2000;10:229-234.
24. Reuss ML, Paneth N, Pinto-Martin JA, Lorenz JM, Susser M: The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med 1996;334:821-827.
25. Rapaport R, Rose SR, Freemark M: Hypothyroxinemia in the preterm infant: The benefits and risks of thyroxine treatment. J Pediatr 2001;139:182-188.
26. Coalson J, Seidner S, Delemos R: Animal models of chronic lung injury; in Bland RD, Coalson J (eds): Chornic Lung Disease in Early Infancy. New York, Dekker, 1999, pp 911-926.
27. Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA: Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999;160:1333-1346.
28. Seidner SR, Jobe AH, Coalson JJ, Ikegami M: Abnormal surfactant metabolism and function in preterm ventilated baboons. Am J Respir Crit Care Med 1998;158:1982-1989.
29. Seidner S, Jobe A, Ikegami M: Surfactant metabolism following late surfactant treatment doses during BPD development in preterm baboons. Pediatr Res 2000;47:367A.
30. Yoder BA, Siler-Khodr T, Winter VT, Coalson JJ: High-frequency oscillatory ventilation: Effects on lung function, mechanics, and airway cytokines in the immature baboon model for neonatal chronic lung disease. Am J Respir Crit Care Med 2000;162:1867-1876.
31. van Wassenaer AG, Kok JH, Endert E, Vulsma T, de Vijlder JJ: Thyroxine administration to infants of less than 30 weeks' gestational age does not increase plasma triiodothyronine concentrations. Acta Endocrinol (Copenh) 1993;129:139-146.
32. Ng PC, Lam CW, Fok TF, Lee CH, Ma KC, Chan IH, Wong E: Refractory hypotension in preterm infants with adrenocortical insufficiency. Arch Child Fetal Neonatal Ed 2001;84:F122-F124.
33. Meijer WJ, Verloove-Vanhorick SP, Brand R, van den Brande JL: Transient hypothyroxinaemia associated with developmental delay in very preterm infants. Arch Dis Child 1992;67:944-947.
34. Leviton A, Paneth N, Reuss ML, Susser M, Allred EN, Dammann O, Kuban K, Van Marter LJ, Pagano M: Hypothyroxinemia of prematurity and the risk of cerebral white matter damage. J Pediatr 1999;134:706-711.
35. van Wassenaer AG, Kok JH, de Vijlder JJ, Briet JM, Smit BJ, Tamminga P, van Baar A, Dekker FW, Vulsma T: Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. N Engl J Med 1997;336:21-26.
36. Briet JM, van Wassenaer AG, Dekker FW, de Vijlder JJ, van Baar A, Kok JH: Neonatal thyroxine supplementation in very preterm children: Developmental outcome evaluated at early school age. Pediatrics 2001;107:712-718.
37. Pepe GJ, Albrecht ED: Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev 1995;16:608-648.
38. Yoder B, Martin H, McCurnin DC, Coalson JJ: Impaired urinary cortisol excretion and early cardiopulmonary dysfunction in immature baboons. Pediatr Res 2002;51:426-432.
39. McIntosh TK: Prolonged alterations in plasma cortisol circadian rhythms following trauma in baboons. Am J Physiol 1987;252:R548-R553.
40. Lye SJ, Sprague CL, Mitchell BF, Challis JR: Activation of ovine fetal adrenal function by pulsatile or continuous administration of adrenocorticotropin (1-24). I. Effects on fetal plasma corticosteroids. Endocrinology 1983;113:770-776.
41. Lu F, Yang K, Challis JR: Characteristics and developmental changes of corticotrophin-releasing hormone-binding sites in the fetal sheep anterior pituitary gland. J Endocrinol 1991;130:223-229.
42. Mayenknecht J, Diederich S, Bahr V, Plockinger U, Oelkers W: Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. J Clin Endocrinol Metab 1998;83:1558-1562.
43. Kamilaris T, Chrousos G: Adrenal disease; in Moore W, Eastman R (eds): Diagnostic Endocrinology. Toronto, Becker, 1990, p 85.
44. Griffin GL, Melby JC: The maternal adrenal cortex; in Tulchinsky D, Little AB (eds): Maternal-fetal Endocrinology. Philadelphia, Saunders Co 1994, p 155.
45. Malaivijitnond S, Takenaka O, Sankai T, Yoshida T, Cho F, Yoshikawa Y: Effects of single and multiple injections of ketamine hydrochloride on serum hormone concentrations in male cynomolgus monkeys. Lab Anim Sci 1998;48:270-274.